Recent Quotes (30 days)

You have no recent quotes
chg | %

CyBio AG  

(Public, ETR:CQJ)   Watch this stock  
Find more results for FRA:CQJ
1.03
Jul 1 - Close
ETR data delayed by 15 mins - Disclaimer
Currency in EUR
Range     -
52 week 0.83 - 1.94
Open     -
Vol. 0.00
Mkt cap 7.42M
P/E 5.77
Div/yield     -
EPS 0.18
Shares 7.20M
Beta     -
Inst. own     -
Apr 22, 2013
CyBio AG Annual Shareholder Meeting
  

Key stats and ratios

Q1 (Mar '12) 2011
Net profit margin 8.62% 10.28%
Operating margin 11.43% 10.14%
EBITD margin - 12.30%
Return on average assets 10.07% 13.32%
Return on average equity 15.19% 21.65%
Employees 95 -
Carbon Disclosure Rating - -

Address

Goeschwitzer Strasse 40
JENA, 07745
Germany
+49-3641-3510 (Phone)
+49-3641-351409 (Fax)

Website links

External links

Discussion Group - Google Finance

Description

CyBio AG is a Germany-based company, providing the development, manufacture and marketing of laboratory systems and equipment, as well as related software. The Company offers systems for the preparation, transport of specified substances, as well as systems for the detection of pharmaceutical and biotechnological agents in those substances. Its core products are simultaneous pipetting and imaging technologies. The Company operates through five subsidiaries, including CyBio Central Europe GmbH, CLS Laborautomationssysteme GmbH i. L. Reutlingen (in liquidation), CyBio US Inc, CyBio Northern Europe Ltd and CyBio Japan Co, Ltd. (in liquidation). Its customers are pharmaceutical and biotechnological companies in the European Union and the United States, as well as academic research institutes.